期刊档案 · GASTROENTEROLOGY & HEPATOLOGY

Journal of Clinical and Translational Hepatology

ISSN 2225-0719 · eISSN 2310-8819 · Xia & He Publishing Inc. · USA · Monthly · 创刊 2013

Journal of Clinical and Translational Hepatology 中科院 医学 3区(2025 年升级版),影响因子 5.92,完全开放获取,APC 约 3,380 美元,近 24 个月 100 篇文章投稿到接收中位 85 天,录用比例约 15%(社区反馈),2025 年发文 104 篇,SCIE、Scopus 收录。

影响因子5.92LetPub 汇总的最新公布值
中科院分区医学 3区2025 年升级版大类 · 2026 新锐版 医学 2区
审稿周期85 天投稿到接收中位数 · 近 24 个月 100 篇文章 · PubMed
版面费3,380 USD完全开放获取
录用比例15%投稿社区平均反馈
年发文量104 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Journal of Clinical and Translational Hepatology 由 Xia & He Publishing Inc. 出版,属中科院医学大类(2025 升级版3区)。按 OpenAlex 近年发文统计,该刊主要发表 Liver Disease Diagnosis and Treatment、Liver Disease and Transplantation、Hepatitis C virus research 等主题的论文,这 3 个主题约占 43.5%,主导子领域为 Hepatology。(根据 OpenAlex 主题统计与中科院分区数据生成)

Journal of Clinical and Translational Hepatology (JCTH) publishes high quality, peer-reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research characterized by a study’s novelty, quality, and ethical conduct in the scientific process, as well as in the communication of the research findings. Each issue includes review articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondence, and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass a rigorous peer review. The open-access publishing model of JCTH avails an international readership, prompting worldwide interest from contributing authors, and helping promote the diverse range of hepatology topics covered in our journal. JCTH welcomes submissions of articles within its topical scope including:Novel discoveries in translational and clinical hepatologyLiver disease mechanismsNovel techniques in research and management of liver diseasesEpidemiological/environmental factors of liver diseasesRole of immune system function in liver diseasesAcute and chronic hepatitisCirrhosisGenetic and metabolic liver diseases and their complicationsHepatobiliary diseasesLiver cancerDrug metabolismBiliary diseasePeritoneal tuberculosis (with portal hypertension) Prof. George Y. Wu is responsible for the scientific quality of publications.JCTH is currently indexed in Science Citation Index Expanded (SCIE) , PubMed and Scopus.JCTH is published by Xia & He Publishing Inc. in association with the Second Affiliated Hospital of Chongqing Medical University.

摘自期刊官网 Aims & Scope

研究方向(LetPub):GASTROENTEROLOGY & HEPATOLOGY

主编 Fusheng Wang出版商官网

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Liver Disease Diagnosis and TreatmentMedicine22.3%
  2. Liver Disease and TransplantationMedicine10.9%
  3. Hepatitis C virus researchMedicine10.4%
  4. Hepatitis B Virus StudiesMedicine9.9%
  5. Hepatocellular Carcinoma Treatment and PrognosisMedicine6%
  6. Liver Diseases and ImmunityMedicine4.8%
  7. Organ Transplantation Techniques and OutcomesMedicine4%
  8. Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics3.4%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 3 区
类别学科分区
大类医学3 区
小类胃肠肝病学GASTROENTEROLOGY & HEPATOLOGY3 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 2 区
类别学科分区
大类医学2 区
小类胃肠肝病学GASTROENTEROLOGY & HEPATOLOGY2 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 3 区
类别学科分区
大类医学3 区
小类胃肠肝病学GASTROENTEROLOGY & HEPATOLOGY4 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PubMed出版商官网

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
5.92LetPub ·
影响因子(出版商公布)
6出版商官网 ·
CiteScore 2026-06
9.6LetPub ·
CiteScore(出版商公布)
9.6出版商官网 ·
SJR 2026-06
1.48LetPub ·
SNIP 2026-06
1.38LetPub ·
h-index
66OpenAlex ·
i10-index
508OpenAlex ·
两年平均被引
3.45OpenAlex ·
自引率
6.7%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
90LetPub ·

逐年发文量 OpenAlex 统计 · 累计 1,108 篇 · 当年数据不完整

年份发文量其中 OA被引
2026848413
2025104104201
2024107107805
20231201201,357
20221561562,367
20211531532,198

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

85 天投稿到接收中位数 · P25–P75 63 天 – 118 天

接收到上线
中位数 28 天(100 篇)
投稿到上线
中位数 119 天
样本
100 篇有投稿与接收日期的文章(窗口内共 213 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
期刊官网数据:平均Median time from submission to first decision: 23 days; Median time from acceptance to online publishing: 22 days网友分享经验:LetPub ·
平均录用比例(社区反馈)
15%LetPub ·
录用率(出版商公布)
15%出版商官网 ·
投稿到首次决定
21 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取OpenAlex

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
出版商官网USD 3,380 / USD 2,200——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点2 项,摘自作者指南
参考文献格式
Vancouver 格式
推荐审稿人
可选 3 位
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型6 种
  1. editorialPlease ensure that any manuscript you submit to JCTH conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internatio…未说明篇幅
  2. hypothesisPlease ensure that any manuscript you submit to JCTH conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internatio…未说明篇幅
  3. letter to the editorAn article that contains substantive and analytical comments on a specific article published in recent issues of JCTH. Comments and conclusions should be addres…未说明篇幅
  4. original articleOriginal research manuscripts should describe experimental and/or clinical studies in biomedicine, including exploratory and hypothesis-driven studies of basic …未说明篇幅
  5. original researchPlease ensure that any manuscript you submit to JCTH conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internatio…未说明篇幅
  6. reviewPlease ensure that any manuscript you submit to JCTH conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internatio…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、开放获取、同行评审、查重
AI 使用 Use of AI Tools by Editors

Editors and editorial board members must protect the confidentiality of manuscripts and editorial communications. They must not upload unpublished manuscripts, peer review reports, decision letters, author responses, or other confidential information to public AI platforms.

原文 ↗出版商官网 ·
作者资格 Author Contributions

作者贡献应以段落形式提供,列出每位作者(以姓名首字母缩写标注)在研究设计、实验实施、数据分析与解释、论文撰写、批判性修改、统计分析、经费支持、行政支持以及技术或物质支持等方面的具体参与情况。 模型中文摘要

The Author Contributions should be provided in paragraph form. The manner in which each author was involved with the study or preparation of the manuscript is listed with the author’s name (shown as initials, within parentheses). Contributions that are acceptable for inclusion as an author are: study design, performance of experiments, analysis and interpretation of data, manuscript writing, criti…

原文 ↗出版商官网 ·
利益冲突 Conflict of Interest Statement

所有作者必须披露近三年内与稿件相关的任何潜在利益冲突(包括财务、职业、个人或其他方面),如咨询、持股、专利许可协议、研究资助、重大报酬、雇佣或董事会职位等;若无利益冲突,应明确声明“作者与本出版物无利益冲突”。 模型中文摘要

All authors are required to disclose any potential conflict of interests (financial, professional, personal, or otherwise) within the past three years that are relevant to the manuscript, including but not limited to consultancies, ownership, equity, patent-licensing agreements, research support, major honoraria, employment or board positions involving a company whose product is mentioned in the m…

原文 ↗出版商官网 ·
数据可用性 Data Sharing Statement

研究类文章鼓励提供数据共享声明,说明读者如何获取共享数据,例如数据已存入某存储库(附DOI或其他持久标识符)、包含在文章内或包含在补充信息文件中。 模型中文摘要

A Data Sharing Statement is encouraged for research articles through which readers will know how to access the shared data. Sample wording: The [TYPE, such as technical appendix, statistical code, or dataset] data used to support the findings of this study have been deposited in the [NAME] repository ([DOI or other persistent identifier]); The [TYPE] data used to support the findings of this study…

原文 ↗出版商官网 ·
开放获取 Open Access

《临床与转化肝病学杂志》采用开放获取出版模式,所有文章根据CC BY-NC 4.0许可协议发布,允许任何人在注明出处的前提下为非商业目的复制、分发或重用这些文章。 模型中文摘要

Journal of Clinical and Translational Hepatology (JCTH) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for public…

原文 ↗出版商官网 ·
同行评审 Peer Review & Editorial Process

所有投稿至JCTH的稿件(包括约稿和自由投稿)均须经过单盲同行评审,即作者无法知晓审稿人身份,评审过程旨在确保研究目标、数据和结论的完整性与透明度。 模型中文摘要

The objective of the peer review process is to ensure the integrity and transparency of the research objectives, data, and conclusions. Editorial Process All manuscripts, solicited and unsolicited, that are submitted to JCTH will be subject to the following single-blind peer review process, meaning that the authors are blinded to the reviewers’ identities. Step 1: Upon submission, the editorial st…

原文 ↗出版商官网 ·
查重 Types of Plagiarism

JCTH将抄袭定义为在未恰当引用或注明原始来源的情况下使用已发表文献中的信息(包括文字描述、图表和数据),所有投稿稿件都将通过Crossref Similarity Check抄袭检测软件进行查重。 模型中文摘要

Plagiarism is defined by the JCTH as use of information, including textual descriptions, figures/tables and data, from a previously published document without proper citation or reference to the original source. All submitted manuscripts will be checked using plagiarism detection software (Crossref Similarity Check).

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Xia & He Publishing Inc.
出版国家或地区
USA
出版语言
English
出版周期
Monthly
创刊年份
2013
ISSN
2225-0719
电子版 ISSN
2310-8819
官方链接

常见问题

关于 Journal of Clinical and Translational Hepatology 的常见问题

Journal of Clinical and Translational Hepatology 是中科院几区期刊?

2025 年升级版分区表中,Journal of Clinical and Translational Hepatology 为医学 3区,小类 胃肠肝病学 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。

Journal of Clinical and Translational Hepatology 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 5.92,CiteScore 为 9.6,h-index 为 66。

Journal of Clinical and Translational Hepatology 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)100 篇已发表文章登记的日期,投稿到接收的中位数为 85 天(四分位 63–118 天);投稿社区反馈的平均审稿速度为期刊官网数据:平均Median time from submission to first decision: 23 days; Median time from acceptance to online publishing: 22 days网友分享经验:,平均录用比例反馈为“15%”;期刊官网公布的录用率为 15%。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Journal of Clinical and Translational Hepatology 的投稿格式要求是什么?

据期刊作者指南:参考文献格式:Vancouver 格式;推荐审稿人:可选 3 位。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Journal of Clinical and Translational Hepatology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Journal of Clinical and Translational Hepatology 被 SCIE、Scopus 收录。期刊官网自述还被 PubMed 收录,该清单未与各数据库逐一核对。

Journal of Clinical and Translational Hepatology 是开放获取期刊吗?版面费多少?

Journal of Clinical and Translational Hepatology 为完全开放获取。APC 约 3,380 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。